Prospects for CD40-directed experimental therapy of human cancer (original) (raw)

Immunotherapy/Biological Therapies

iwan sumantri

Neuro-Oncology, 2013

View PDFchevron_right

Application of Novel Molecular Biology in Cancer Therapy

asadollah asadi

Basic & Clinical Cancer Research, 2022

View PDFchevron_right

Targeted Cancer Therapy: From Scratch to Clinical Trials

Ojas Gupta

International Journal of High School Research, 2021

View PDFchevron_right

Prognostic Value of CD40 in Adult Soft Tissue Sarcomas

Vincenzo Ravo

Clinical Cancer Research, 2004

View PDFchevron_right

Immunotherapy: A Novel Approach to Fight Cancer

Fateh Singh

International Journal of Current Microbiology and Applied Sciences, 2020

View PDFchevron_right

Genetically Driven Target Tissue Overexpression of CD40: A Novel Mechanism in Autoimmune Disease

Rauf Latif

The Journal of Immunology, 2012

View PDFchevron_right

Antitumor Activity of an Oncolytic Adenoviral-CD40 Ligand (CD154) Transgene Construct in Human Breast Cancer Cells

Rubén Hernández-alcoceba

Clinical Cancer Research, 2009

View PDFchevron_right

Current trends of anticancer immunochemotherapy

NICOLE DIANNE CASTILLO PRADA

OncoImmunology, 2013

View PDFchevron_right

Interaction with Fc RIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody

Sjef Verbeek

The Journal of Immunology, 2011

View PDFchevron_right

Preclinical pharmacokinetics, pharmacodynamics, and activity of a humanized anti-CD40 antibody (SGN-40) in rodents and non-human primates

T. Gelzleichter, Iqbal Grewal, Walter Darbonne

British Journal of Pharmacology, 2006

View PDFchevron_right

Immune gene therapy of cancer

Reza Elahi

TURKISH JOURNAL OF MEDICAL SCIENCES, 2020

View PDFchevron_right

Toward Increased Sensitivity and Specificity in the Treatment of Neoplastic Diseases

Harold Slavkin

Journal of the American Dental Association, 1998

View PDFchevron_right

Cancer chemoprevention

Lynne Howells

European Journal of Cancer Prevention, 2014

View PDFchevron_right

Cancer research: On the offensive

Alison Abbott

Nature, 2002

View PDFchevron_right

Bioassays for Anticancer Activities

Danielle Skropeta

Methods in Molecular Biology, 2013

View PDFchevron_right

Cancer immunotherapy: present scenarios and the future of immunotherapy

Gaurisankar Sa

The Nucleus, 2019

View PDFchevron_right

Role of OX40 and its ligand as costimulatory modulators in cancer immunotherapy

Dr Aliya Sani, Syed Zaryab

AIMS Molecular Science, 2021

View PDFchevron_right

CAR-T Cell Therapy for Cancer

ismail al-janabi

˜Al-œRafidain journal of medical sciences., 2024

View PDFchevron_right

International Journal of Cancer Therapy and Oncology

Alia Attia

2016

View PDFchevron_right

Advances in the preclinical testing of cancer therapeutic hypotheses

Giordano Caponigro

Nature Reviews Drug Discovery, 2011

View PDFchevron_right

CD38 and bone marrow microenvironment

Fabio Molinette

Frontiers in Bioscience, 2014

View PDFchevron_right

Cancer Vaccines and Tumor Immunity

Veronica Preda

2007

View PDFchevron_right

Loss of CD55 Is Associated with Aggressive Breast Tumors

Sarah Pinder

Clinical Cancer Research, 2004

View PDFchevron_right

Investigation of the SV40 – Human Cancer Association: Look for the Full Signature of the Virus

D. Rollison

Disease Markers, 2001

View PDFchevron_right

Functional Dichotomy in CD40 Reciprocally Regulates Effector T Cell Functions

Reena Agrawal

The Journal of Immunology, 2006

View PDFchevron_right